Logo image of MNTS

MOMENTUS INC (MNTS) Stock Fundamental Analysis

NASDAQ:MNTS - Nasdaq - US60879E2000 - Common Stock

7.6  -0.68 (-8.21%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MNTS. MNTS was compared to 65 industry peers in the Aerospace & Defense industry. MNTS may be in some trouble as it scores bad on both profitability and health. MNTS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MNTS had negative earnings in the past year.
In the past year MNTS has reported a negative cash flow from operations.
In multiple years MNTS reported negative net income over the last 5 years.
MNTS had a negative operating cash flow in each of the past 5 years.
MNTS Yearly Net Income VS EBIT VS OCF VS FCFMNTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

The Return On Assets of MNTS (-263.65%) is worse than 98.44% of its industry peers.
Industry RankSector Rank
ROA -263.65%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNTS Yearly ROA, ROE, ROICMNTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -100 -200

1.3 Margins

MNTS has a Gross Margin of 78.33%. This is amongst the best in the industry. MNTS outperforms 98.44% of its industry peers.
The Profit Margin and Operating Margin are not available for MNTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MNTS Yearly Profit, Operating, Gross MarginsMNTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20K -20K

More info and screens

0

2. Health

2.1 Basic Checks

MNTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for MNTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MNTS Yearly Shares OutstandingMNTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 1M 2M 3M 4M
MNTS Yearly Total Debt VS Total AssetsMNTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

MNTS has an Altman-Z score of -47.83. This is a bad value and indicates that MNTS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -47.83, MNTS is not doing good in the industry: 96.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -47.83
ROIC/WACCN/A
WACC11.57%
MNTS Yearly LT Debt VS Equity VS FCFMNTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.38 indicates that MNTS may have some problems paying its short term obligations.
The Current ratio of MNTS (0.38) is worse than 96.88% of its industry peers.
A Quick Ratio of 0.38 indicates that MNTS may have some problems paying its short term obligations.
MNTS has a worse Quick ratio (0.38) than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
MNTS Yearly Current Assets VS Current LiabilitesMNTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

MNTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.62%, which is quite impressive.
The Revenue has grown by 30.29% in the past year. This is a very strong growth!
EPS 1Y (TTM)45.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
Revenue 1Y (TTM)30.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-68.44%

3.2 Future

The Earnings Per Share is expected to grow by 3.15% on average over the next years.
MNTS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 61.54% yearly.
EPS Next Y74.76%
EPS Next 2Y3.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year63.1%
Revenue Next 2Y61.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

MNTS Yearly Revenue VS EstimatesMNTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
MNTS Yearly EPS VS EstimatesMNTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MNTS. In the last year negative earnings were reported.
Also next year MNTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MNTS Price Earnings VS Forward Price EarningsMNTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MNTS Per share dataMNTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.15%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOMENTUS INC

NASDAQ:MNTS (1/22/2025, 11:43:09 AM)

7.6

-0.68 (-8.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-15 2024-11-15/amc
Earnings (Next)N/A N/A
Inst Owners1.71%
Inst Owner Change0%
Ins Owners0.72%
Ins Owner Change4.23%
Market Cap18.32M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-54.97%
Min Revenue beat(2)-88.96%
Max Revenue beat(2)-20.98%
Revenue beat(4)1
Avg Revenue beat(4)-39.18%
Min Revenue beat(4)-88.96%
Max Revenue beat(4)0.29%
Revenue beat(8)2
Avg Revenue beat(8)31.76%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.42
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-23.72
EYN/A
EPS(NY)-34.27
Fwd EYN/A
FCF(TTM)-11.11
FCFYN/A
OCF(TTM)-11.08
OCFYN/A
SpS1.18
BVpS-2.24
TBVpS-2.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -263.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.33%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6%
Cap/Sales 1.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z -47.83
F-Score4
WACC11.57%
ROIC/WACCN/A
Cap/Depr(3y)122.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)399.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
EPS Next Y74.76%
EPS Next 2Y3.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-68.44%
Revenue Next Year63.1%
Revenue Next 2Y61.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y69.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.75%
OCF growth 3YN/A
OCF growth 5YN/A